...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Synthesis and inhibitory activity on hepatitis C virus RNA replication of 4-(1,1,1,3,3,3-hexafluoro-2-hydroxy-2-propyl)aniline analogs
【24h】

Synthesis and inhibitory activity on hepatitis C virus RNA replication of 4-(1,1,1,3,3,3-hexafluoro-2-hydroxy-2-propyl)aniline analogs

机译:4-(1,1,1,3,3,3-六氟-2-羟基-2-丙基)苯胺类似物的丙型肝炎病毒RNA复制的合成及其抑制活性

获取原文
获取原文并翻译 | 示例
           

摘要

Using our recently developed assay system for full-genome-length hepatitis C virus (HCV) RNA replication in human hepatoma-derived Li23 cells (ORL8), we identified 4-(1,1,1,3,3,3-hexafluoro-2-hydroxy-2-propyl)aniline analog 1a as a novel HCV inhibitor. Structural modifications of 1a provided a series of sulfonamides 7 with much more potent HCV RNA replication-inhibitory activity than ribavirin. Compound 7a showed an additive anti-HCV effect in combination with standard anti-HCV therapy (IFN-α plus ribavirin). Since 7a generated reactive oxygen species (ROS) in the ORL8 system and its anti-HCV activity was blocked by vitamin E, its anti-HCV activity may be mediated at least in part by ROS.
机译:使用我们最近开发的用于全基因组丙型肝炎病毒(HCV)RNA在人肝癌衍生的Li23细胞(ORL8)中复制的测定系统,我们确定了4-(1,1,1,3,3,3-hexafluoro- 2-羟基-2-丙基)苯胺类似物1a作为新型HCV抑制剂。 1a的结构修饰为一系列磺酰胺7提供了比利巴韦林更有效的HCV RNA复制抑制活性。化合物7a与标准抗HCV治疗(IFN-α加利巴韦林)组合显示出加性抗HCV作用。由于7a在ORL8系统中生成了活性氧(ROS),并且其抗HCV活性被维生素E阻断,因此其抗HCV活性可能至少部分地由ROS介导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号